Skip to main content

Articles

258 result(s) within Volume 13 of Radiation Oncology

Page 1 of 6

  1. Small cell lung cancer (SCLC) can recur in the brain after whole-brain irradiation (WBI). We documented outcomes after treatment of such recurrences and sought predictors of local control and overall survival ...

    Authors: Ryoko Suzuki, Xiong Wei, Pamela K. Allen, James W. Welsh, James D. Cox, Ritsuko Komaki and Steven H. Lin
    Citation: Radiation Oncology 2018 13:258
  2. Local progression-free survival (LPFS = stable or improved motor function/resolution of paraplegia during RT without in-field recurrence following RT) is important when treating metastatic spinal cord compress...

    Authors: Dirk Rades, Antonio J. Conde-Moreno, Jon Cacicedo, Theo Veninga, Barbara Segedin, Karmen Stanic and Steven E. Schild
    Citation: Radiation Oncology 2018 13:257
  3. PRIMO is a dose verification system based on the general-purpose Monte Carlo radiation transport code penelope, which implements an accurate physics model of the interaction cross sections and the radiation trans...

    Authors: Miguel Rodriguez, Josep Sempau, Christian Bäumer, Beate Timmermann and Lorenzo Brualla
    Citation: Radiation Oncology 2018 13:256
  4. Elective use of radiation therapy to treat regionally involved lymph nodes (LNs) after radical surgery for esophageal squamous cell carcinoma (ESCC) is controversial. We studied metastasis patterns through a p...

    Authors: Xiaofei Zhang, Xi Yang, Jianjiao Ni, Yida Li, Liqing Zou, Li Chu, Xiao Chu, Fan Xia and Zhengfei Zhu
    Citation: Radiation Oncology 2018 13:255
  5. This study aimed to evaluate the inter-fraction set-up error and intra-fraction motion during reverse semi-decubitus (RSD) breast radiotherapy, and to determine a planning target volume (PTV) margin.

    Authors: Jie Lee, Shih-Hua Liu, Jhen-Bin Lin, Meng-Hao Wu, Chieh-Ju Wu, Hung-Chi Tai, Shih-Ming Hsu, Yin-Ju Chen, Jo-Chiao Tai and Yu-Jen Chen
    Citation: Radiation Oncology 2018 13:254
  6. Although stereotactic radiotherapy (SRT) for vestibular schwannoma has demonstrated excellent local control rates, hearing deterioration is often reported after treatment. We therefore wished to assess the cha...

    Authors: A. van Linge, R. van Os, N. Hoekstra, B. Heijmen, L. Stienstra, A. Dallenga, J. Wolbers and A. Mendez Romero
    Citation: Radiation Oncology 2018 13:253
  7. Stereotactic radiosurgery (SRS) has emerged as a common adjuvant modality used with surgery for resectable brain metastases (BMs). However, the optimal sequence of the multi-modality therapy has not been estab...

    Authors: Wei X. Huff, Namita Agrawal, Scott Shapiro, James Miller, Charles Kulwin, Mitesh Shah, Jesse J. Savage, Troy Payner, Alexander Vortmeyer, Gordon Watson and Mahua Dey
    Citation: Radiation Oncology 2018 13:252
  8. The dismal overall survival (OS) prognosis of glioblastoma, even after trimodal therapy, can be attributed mainly to the frequent incidence of intracranial relapse (ICR), which tends to present as an in-field ...

    Authors: Sebastian Zschaeck, Peter Wust, Reinhold Graf, Martin Misch, Julia Onken, Pirus Ghadjar, Harun Badakhshi, Julian Florange, Volker Budach and David Kaul
    Citation: Radiation Oncology 2018 13:251
  9. The role of the dose escalation strategy in brain radiotherapy for small cell lung cancer (SCLC) patients with brain metastases (BMs) has not been identified. This study aims to determine whether an additional...

    Authors: Han Sun, Liming Xu, Youyou Wang, Junhua Zhao, Kunpeng Xu, Jing Qi, Zhiyong Yuan, Lujun Zhao and Ping Wang
    Citation: Radiation Oncology 2018 13:250
  10. Concurrent chemoradiotherapy (CCRT) is effective in the treatment of locally advanced cervical squamous cell carcinoma (SCC). However, whether treatment outcomes of cervical adenocarcinoma are equivalent to SC...

    Authors: Ke Hu, Weiping Wang, Xiaoliang Liu, Qingyu Meng and Fuquan Zhang
    Citation: Radiation Oncology 2018 13:249
  11. To report our experience in planning and delivering total marrow irradiation (TMI) and total marrow and lymphatic irradiation (TMLI) in patients with hematologic malignancies.

    Authors: Zhirong Bao, Hongli Zhao, Dajiang Wang, Jian Gong, Yahua Zhong, Yu Xiong, Di Deng, Conghua Xie, An Liu, Xiaoyong Wang and Hui Liu
    Citation: Radiation Oncology 2018 13:248
  12. The survival benefit of PCI in ES-SCLC reported by a European randomized trial (RCT) in 2007 was not replicated by a Japanese RCT published in 2017. This study aimed to evaluate the uptake of PCI before and af...

    Authors: Yu Yang Soon, Huili Zheng, Shaun Zhirui Ho, Wee Yao Koh, Cheng Nang Leong, Jeremy Chee Seong Tey, Balamurugan Vellayappan, Swee Peng Yap, Ivan Weng Keong Tham and Kam Weng Fong
    Citation: Radiation Oncology 2018 13:247
  13. The standard treatment for superficial esophageal cancer (SEC) involving muscularis mucosal (T1a-MM) or submucosal (T1b) invasion has been the surgical resection of the esophagus. However, esophagectomy with e...

    Authors: Gen Suzuki, Hideya Yamazaki, Norihiro Aibe, Koji Masui, Naomi Sasaki, Daisuke Shimizu, Takuya Kimoto, Atsushi Shiozaki, Osamu Dohi, Hitoshi Fujiwara, Takeshi Ishikawa, Hirotaka Konishi, Yuji Naito, Eigo Otsuji and Kei Yamada
    Citation: Radiation Oncology 2018 13:246
  14. Oesophageal cancer with airway invasion presents a challenge for therapy and often has serious complications. We analysed the clinical outcomes of radiation therapy (RT) in patients with clinical T4b oesophage...

    Authors: Hakyoung Kim, Dongryul Oh, Yong Chan Ahn, Keunchil Park, Myung-Ju Ahn, Se-Hoon Lee, Jong-Mu Sun, Young Mog Shim, Jae Ill Zo, Yong Soo Choi, Hong Kwan Kim and Jong Ho Cho
    Citation: Radiation Oncology 2018 13:245
  15. Dose calculations in intraoperative electron radiation therapy (IOERT) rely on the conventional assumption of water-equivalent tissues at the applicator end, which defines a flat irradiation surface. However, ...

    Authors: Verónica García-Vázquez, Begoña Sesé-Lucio, Felipe A. Calvo, Juan J. Vaquero, Manuel Desco and Javier Pascau
    Citation: Radiation Oncology 2018 13:243
  16. Since the introduction of tumor tracking in radiotherapy, it is possible to ensure a precise irradiation of moving targets. To follow the tumor movement, most systems rely on the detection of implanted markers...

    Authors: Marc Ziegler, Tobias Brandt, Sebastian Lettmaier, Rainer Fietkau and Christoph Bert
    Citation: Radiation Oncology 2018 13:242
  17. Automatic multi-criteria optimization is necessary for intensity modulated radiation therapy (IMRT) because of low planning efficiency and large plan quality uncertainty in current clinical practice. Most stud...

    Authors: Yanhua Mai, Fantu Kong, Yiwei Yang, Linghong Zhou, Yongbao Li and Ting Song
    Citation: Radiation Oncology 2018 13:241
  18. Advanced clinical applications, such as dose accumulation and adaptive radiation therapy, require deformable image registration (DIR) algorithms capable of voxel-wise accurate mapping of treatment dose or func...

    Authors: An Qin, Dan Ionascu, Jian Liang, Xiao Han, Nicolette O’Connell and Di Yan
    Citation: Radiation Oncology 2018 13:240
  19. Peer review systems within radiation oncology are important to ensure quality radiation care. Several individualized methods for radiation oncology peer review have been described. However, despite the importa...

    Authors: Ashley A. Albert, William N. Duggar, Rahul P. Bhandari, Toms Vengaloor Thomas, Satyaseelan Packianathan, Robert M. Allbright, Madhava R. Kanakamedala, Divyang Mehta, Chunli Claus Yang and Srinivasan Vijayakumar
    Citation: Radiation Oncology 2018 13:239
  20. Volumetric shrinkage of normal tissues such as salivary glands, kidneys, hippocampus are observed after radiotherapy. We aimed to assess the alterations in pancreatic volume of patients who received abdominal ...

    Authors: Cengiz Gemici, Gokhan Yaprak, Sevim Ozdemir, Tamer Baysal, Ozgur Ozan Seseogullari and Hazan Ozyurt
    Citation: Radiation Oncology 2018 13:238
  21. Neoadjuvant radio- or chemoradiation (nIRT) therapy is the standard treatment for loco-regional advanced rectal cancer patients of the lower or middle third. Currently, intensity modulated radiation therapy (I...

    Authors: Hendrik Dapper, Iván Rodríguez, Stefan Münch, Jan C. Peeken, Kai Borm, Stephanie E. Combs and Daniel Habermehl
    Citation: Radiation Oncology 2018 13:237
  22. To introduce the benefits of tangent-based volumetric modulated arc therapy (TVMAT), an innovative radiotherapy planning technique, compared with traditional volumetric modulated arc therapy (VMAT) for advance...

    Authors: Pei-Chieh Yu, Ching-Jung Wu, Hsin-Hua Nien, Louis Tak Lui, Suzun Shaw and Yu-Lun Tsai
    Citation: Radiation Oncology 2018 13:236
  23. To compare the clinical outcome in prostate cancer patients treated with radiotherapy using two forms of image guidance: bone-based (BB) or fiducial-based (FB).

    Authors: Aleksandra Napieralska, Wojciech Majewski, Roland Kulik, Grzegorz Głowacki and Leszek Miszczyk
    Citation: Radiation Oncology 2018 13:235
  24. The aim of this study was to evaluate long-term efficacy and survival prognostic factors of stereotactic body radiation therapy (SBRT) for un-resectable liver metastases in patients enrolled in a prospective p...

    Authors: Marta Scorsetti, Tiziana Comito, Elena Clerici, Ciro Franzese, Angelo Tozzi, Cristina Iftode, Lucia Di Brina, Pierina Navarria, Pietro Mancosu, Giacomo Reggiori, Antonella Fogliata, Stefano Tomatis, Guido Torzilli and Luca Cozzi
    Citation: Radiation Oncology 2018 13:234
  25. The purpose of this study is to compare the efficacy and safety of concurrent chemoradiotherapy (CCRT) versus chemotherapy alone for patients with stage IV esophageal squamous cell carcinoma (ESCC).

    Authors: Jiahua Lyu, Tao Li, Qifeng Wang, Fang Li, Peng Diao, Li Liu, Churong Li and Jinyi Lang
    Citation: Radiation Oncology 2018 13:233
  26. The usefulness of particle therapy for skull base chordoma has not been established. The aim of this retrospective study was to analyse the treatment outcomes of proton therapy (PT) and carbon ion therapy (CIT...

    Authors: Masaru Takagi, Yusuke Demizu, Fumiko Nagano, Kazuki Terashima, Osamu Fujii, Dongcun Jin, Masayuki Mima, Yasue Niwa, Kuniaki Katsui, Masaki Suga, Tomohiro Yamashita, Takashi Akagi, Koh-ichi Sakata, Nobukazu Fuwa and Tomoaki Okimoto
    Citation: Radiation Oncology 2018 13:232
  27. Tangent-based intensity modulated radiation therapy (TIMRT) is a common adjuvant radiotherapy strategy for breast cancer patients. This study compared the dosimetric characteristics of tangent-based volumetric...

    Authors: Pei-Chieh Yu, Ching-Jung Wu, Yu-Lun Tsai, Suzun Shaw, Shih-Yu Sung, Louis Tak Lui and Hsin-Hua Nien
    Citation: Radiation Oncology 2018 13:231
  28. To evaluate the treatment outcome and prostate-specific antigen (PSA) change after stereotactic body radiotherapy (SBRT) for localized prostate cancer.

    Authors: Younghee Park, Hae Jin Park, Won Il Jang, Bae Kwon Jeong, Hun-Jung Kim and Ah Ram Chang
    Citation: Radiation Oncology 2018 13:230
  29. A new strategy is introduced combining the use of Multi-Criteria Optimization-based Trade-Off Exploration (TO) and RapidPlan™ (RP) for the selection of optimisation parameters that improve the trade-off betwee...

    Authors: Eliane Miguel-Chumacero, Garry Currie, Abigail Johnston and Suzanne Currie
    Citation: Radiation Oncology 2018 13:229
  30. Neoadjuvant radio(chemo)therapy of non-metastasized, borderline resectable or unresectable locally advanced pancreatic cancer is complex and prone to cause side-effects, e.g., in gastrointestinal organs. Inten...

    Authors: Sarah Stefanowicz, Kristin Stützer, Sebastian Zschaeck, Annika Jakobi and Esther G. C. Troost
    Citation: Radiation Oncology 2018 13:228
  31. The ano-inguinal lymphatic drainage (AILD) is located in the subcutaneous adipose tissue of the proximal medial thigh. Currently, there are no recommendations for an inclusion of the ‘true’ AILD in the clinica...

    Authors: Hendrik Dapper, Markus Oechsner, Christoph Hirche, Stefan Münch, Christina Sauter, Kai Borm, Jan C. Peeken, Stephanie E. Combs and Daniel Habermehl
    Citation: Radiation Oncology 2018 13:227
  32. Following publication of the original article [1], the authors reported that one of the authors’ names was processed incorrectly.

    Authors: J. Krayenbuehl, M. Zamburlini, S. Ghandour, M. Pachoud, S. Tanadini-Lang, J. Tol, M. Guckenberger and W. F. A. R. Verbakel
    Citation: Radiation Oncology 2018 13:225

    The original article was published in Radiation Oncology 2018 13:170

  33. Patients with recurrent retroperitoneal and pelvic region tumors often require multimodal therapies. Intraoperative radiation therapy (IORT) can deliver high-dose radiation to tumor beds, even if first-line ex...

    Authors: Tharcisio Machado Coelho, Ricardo César Fogaroli, Antonio Cassio Assis Pellizzon, Douglas Guedes De Castro, Guilherme Rocha Melo Gondim, Maria Leticia Gobo Silva, Michael Jenwei Chen and Henderson Ramos
    Citation: Radiation Oncology 2018 13:224
  34. Currently, the standard treatment for locally advanced cervical cancer patients is concurrent chemoradiotherapy. Here we aim to evaluate therapeutic efficacy, treatment failure, toxicity and prognostic factors...

    Authors: Qingyu Meng, Weiping Wang, Xiaoliang Liu, Xiaorong Hou, Xin Lian, Shuai Sun, Junfang Yan, Zhikai Liu, Zheng Miao, Ke Hu and Fuquan Zhang
    Citation: Radiation Oncology 2018 13:223
  35. The dosimetric leaf gap (DLG) and multileaf collimator (MLC) transmission are two important systematic parameters used to model the rounded MLC leaf ends effect when commissioning an Eclipse treatment planning...

    Authors: Chih-Yuan Lin, An-Cheng Shiau, Jin-Huei Ji, Chia-Jung Lee, Ti-Hao Wang, Shu-Hui Hsu and Ji-An Liang
    Citation: Radiation Oncology 2018 13:222
  36. It has been reported that proximity of the tumor to the optic disc and macula, and radiation dose to the critical structures are substantial risk factors for vision loss following plaque brachytherapy. However...

    Authors: Yongsook C. Lee, Shih-Chi Lin and Yongbok Kim
    Citation: Radiation Oncology 2018 13:221
  37. Cells in solid tumours are variably hypoxic and hence resistant to radiotherapy - the essential role of oxygen in the efficiency of irradiation has been acknowledged for decades. However, the currently availab...

    Authors: Olli Metsälä, Joose Kreutzer, Heidi Högel, Petra Miikkulainen, Pasi Kallio and Panu M. Jaakkola
    Citation: Radiation Oncology 2018 13:220
  38. To propose an easily applicable segmentation method (perPET-RT) for delineation of tumour volume during radiotherapy on interim fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomogr...

    Authors: J. Ganem, S. Thureau, I. Gardin, R. Modzelewski, S. Hapdey and P. Vera
    Citation: Radiation Oncology 2018 13:219
  39. This study was performed to evaluate skin toxicity during modern three-dimensional conformal radiotherapy (3D-CRT) and to evaluate the importance of dose distribution and patient related factors.

    Authors: Kai J. Borm, Maximilian Loos, Markus Oechsner, Michael C. Mayinger, Daniela Paepke, Marion B. Kiechle, Stephanie E. Combs and Marciana N. Duma
    Citation: Radiation Oncology 2018 13:218
  40. A high neutrophil-to-lymphocyte ratio (NLR) is a marker of systemic inflammation and together with the platelet-to-lymphocyte ratio (PLR) is associated with worse outcomes in several solid tumors. We investiga...

    Authors: Beat Bojaxhiu, Arnoud J. Templeton, Olgun Elicin, Mohamed Shelan, Kathrin Zaugg, Marc Walser, Roland Giger, Daniel M. Aebersold and Alan Dal Pra
    Citation: Radiation Oncology 2018 13:216
  41. Cancer cachexia is a prevalent symptom of head and neck neoplasms. The reduction in skeletal muscle mass is one of the main characteristics which can lead to poor physical functioning. The purposes of this pil...

    Authors: Manuel Grote, Cornelius Maihöfer, Martin Weigl, Patricia Davies-Knorr and Claus Belka
    Citation: Radiation Oncology 2018 13:215
  42. Dose escalation of conventionally fractionated radiation therapy (CFRT) above 45–54 Gy has an unclear survival benefit. Prior National Cancer Database (NCDB) analyses have shown improved overall survival with ...

    Authors: Sung Jun Ma, Kavitha M. Prezzano, Gregory M. Hermann and Anurag K. Singh
    Citation: Radiation Oncology 2018 13:214
  43. To determine the prognostic impact of comorbidity and age in medically inoperable early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiotherapy (SBRT) using the age-adjusted Charls...

    Authors: Julia Dreyer, Michael Bremer and Christoph Henkenberens
    Citation: Radiation Oncology 2018 13:213
  44. This was a prespecified secondary analysis of a randomized trial that analyzed bone density and pain response following fractionated intensity-modulated radiotherapy (IMRT) versus three-dimensional conformal r...

    Authors: Tanja Sprave, Vivek Verma, Robert Förster, Ingmar Schlampp, Katharina Hees, Thomas Bruckner, Tilman Bostel, Rami Ateyah El Shafie, Thomas Welzel, Nils Henrik Nicolay, Jürgen Debus and Harald Rief
    Citation: Radiation Oncology 2018 13:212
  45. [18F] fluorodeoxyglucose positron emission tomography/computed tomography ([18F] FDG-PET/CT) may be used for tumor staging and prognosis in several tumors but its role in rectal cancer is still debated. The ai...

    Authors: Letizia Deantonio, Angela Caroli, Erinda Puta, Daniela Ferrante, Francesco Apicella, Lucia Turri, Gianmauro Sacchetti, Marco Brambilla and Marco Krengli
    Citation: Radiation Oncology 2018 13:211
  46. HOTAIR was known to enhance radioresistance in several cancers. However, the function of HOTAIR on radioresistance involving the regulation of HIF-1α in cervical cancer has not been reported.

    Authors: Ning Li, Dan-dan Meng, Ling Gao, Yue Xu, Pei-jie Liu, Yong-wei Tian, Zhen-ying Yi, Yan Zhang, Xiao-jing Tie and Zhi-qiao Xu
    Citation: Radiation Oncology 2018 13:210
  47. To evaluate long-term IPSS score and urinary quality of life after radiotherapy for prostate cancer, in patients with prior history of surgical treatment for benign prostatic hyperplasia (BPH).

    Authors: Mélanie Guilhen, Christophe Hennequin, Idir Ouzaid, Ingrid Fumagalli, Valentine Martin, Sophie Guillerm, Pierre Mongiat-Artus, Vincent Ravery, François Desgrandchamps and Laurent Quéro
    Citation: Radiation Oncology 2018 13:209

Annual Journal Metrics

  • 2022 Citation Impact
    3.6 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.370 - SNIP (Source Normalized Impact per Paper)
    1.037 - SJR (SCImago Journal Rank)

    2023 Speed
    16 days submission to first editorial decision for all manuscripts (Median)
    132 days submission to accept (Median)

    2023 Usage 
    1,958,690 downloads
    605 Altmetric mentions